Welcome again, to Day 2 of ASMS 2009
Welcome again, to Day 2 of ASMS 2009. We?re pleased to bring you our continued coverage from Philadelphia, Pennsylvania. ASMS is in full swing, and last night?s hospitality suites were as crowded as ever, as you might imagine. Tonight promises to be another crowded night at the Marriott, but before then, there is a whole day of mass spectrometry-related science.
Welcome again, to Day 2 of ASMS 2009. We’re pleased to bring you our continued coverage from Philadelphia, Pennsylvania. ASMS is in full swing, and last night’s hospitality suites were as crowded as ever, as you might imagine. Tonight promises to be another crowded night at the Marriott, but before then, there is a whole day of mass spectrometry-related science.
Today’s sessions look particularly interesting, and I personally plan to attend “Quantitative Intact Proteomics” which looks like one of the most intriguing. One of the highlights I’m looking forward to is “Quantitative Top-Down Proteomics and Systems Biology of Colon Cancer,” in which new methods of colon cancer diagnosis are explored. Gel-based proteomics is used to identify significantly changing proteins, and the implications for cancer research will be profound. Another highlight is “Differential Gel Electrophoresis Examination of Asian Ash Tree Resistance to Emerald Ash Borer Attack Versus North American Ash Tree Susceptibility.” Here, gel electrophoresis is used for analysis of a variety of ash trees from around the world, and this looks to be one of those good presentations that goes off the beaten track a little. The remainder of the session looks to be equally informative, as there are few topics in the field as worthwhile and interesting as cancer research.
Once again, I would like to invite as many readers as possible to stop by Spectroscopy’s booth, #39, and say hello. These events are a great chance to meet and greet all of the colleagues and associates that you don’t get a chance to see on a regular basis, so it’s a great opportunity to get acquainted or reacquainted.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
